Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Hypertension Secondary to Heart Failure With Preserved Systolic Function: a Target of Phosphodiesterase - 5 Inhibition in a 1- Year Duration Study

NCT01156636 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT01156636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01156636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Hypertension Secondary to Heart Failure With Preserved Systolic Function: a Target of Phosphodiesterase - 5 Inhibition in a 1- Year Duration Study
Lead sponsor
University of Milan
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2006
Completion date
December 31, 2009
Enrollment
44 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure, pulmonary hypertension